Immunomodulators Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Immunomodulators Market to 2027 - Global Analysis and Forecasts by Product (Immunosuppressant, Immunostimulants); Application (Oncology, Respiratory, HIV, Others) and Geography

Report Code: TIPRE00004066 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Immunomodulator is a chemical agent which regulates or normalizes the human immune system. Immunomodulators can be used for the treatment of ulcerative colitis (UC), inflammatory bowel disease (IBD), autoimmune disease and Crohn's disease (CD). Immunomodulators are also used in organ transplantations. Immunomodulators are generally used in combination with steroids in order to accelerate the effect of immunomodulators.

MARKET DYNAMICS
Growing number of organ transplantation cases, growing prevalence of autoimmune diseases, increasing prevalence of inflammatory bowel disease, high rates of diagnosis and treatment of the aforementioned disorders, growing awareness about autoimmune disorders, huge availability of immunomodulators are few factors driving the global immunomodulator market. Furthermore, rising investments in R&D are also propelling the global immunomodulators market during the forecast period. Whereas, the global market is likely to face restrains from stringent regulatory policies regarding immunomodulators.

MARKET SCOPE
The "Global Immunomodulators Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Immunomodulators market with detailed market segmentation by product, application and geography. The global immunomodulators market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Immunomodulators market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global immunomodulators market is segmented on the basis of products and application. Based on products, the market is segmented as Immunosuppressant and Immunostimulants. Immunosuppressant market is further segmented into antibodies, antimetabolites, calcineurin inhibitors, glucocorticoid and others. Immunostimulants market is further segmented into vaccines, antibodies and others. On the basis of application, the global immunomodulators market is segmented into oncology, respiratory, HIV and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global immunomodulators market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The immunomodulators market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Immunomodulators market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Immunomodulators market in these regions.

MARKET PLAYERS
The reports cover key developments in the Immunomodulators market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Immunomodulators market are anticipated to lucrative growth opportunities in the future with the rising demand for Immunomodulators in the global market. Below mentioned is the list of few companies engaged in the Immunomodulators market.

The report also includes the profiles of key Immunomodulators market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • F. Hoffmann-La Roche Ltd.
  • Amgen, Inc.
  • Abbott Laboratories
  • Johnson & Johnson
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Biogen Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Immunomodulators Market - By Product
1.3.2 Immunomodulators Market - By Application
1.3.3 Immunomodulators Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. IMMUNOMODULATORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IMMUNOMODULATORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IMMUNOMODULATORS MARKET - GLOBAL MARKET ANALYSIS
6.1. IMMUNOMODULATORS - GLOBAL MARKET OVERVIEW
6.2. IMMUNOMODULATORS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. IMMUNOMODULATORS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. IMMUNOSUPPRESSANT
7.3.1. Overview
7.3.2. Immunosuppressant Market Forecast and Analysis
7.3.3. Antibodies Market
7.3.3.1. Overview
7.3.3.2. Antibodies Market Forecast and Analysis
7.3.4. Antimetabolites Market
7.3.4.1. Overview
7.3.4.2. Antimetabolites Market Forecast and Analysis
7.3.5. Calcineurin inhibitors Market
7.3.5.1. Overview
7.3.5.2. Calcineurin inhibitors Market Forecast and Analysis
7.3.6. Glucocorticoid Market
7.3.6.1. Overview
7.3.6.2. Glucocorticoid Market Forecast and Analysis
7.3.7. Others Market
7.3.7.1. Overview
7.3.7.2. Others Market Forecast and Analysis
7.4. IMMUNOSTIMULANTS
7.4.1. Overview
7.4.2. Immunostimulants Market Forecast and Analysis
7.4.3. Vaccines Market
7.4.3.1. Overview
7.4.3.2. Vaccines Market Forecast and Analysis
7.4.4. Antibodies Market
7.4.4.1. Overview
7.4.4.2. Antibodies Market Forecast and Analysis
7.4.5. Others Market
7.4.5.1. Overview
7.4.5.2. Others Market Forecast and Analysis
8. IMMUNOMODULATORS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. RESPIRATORY
8.4.1. Overview
8.4.2. Respiratory Market Forecast and Analysis
8.5. HIV
8.5.1. Overview
8.5.2. HIV Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. IMMUNOMODULATORS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Immunomodulators Market Overview
9.1.2 North America Immunomodulators Market Forecasts and Analysis
9.1.3 North America Immunomodulators Market Forecasts and Analysis - By Product
9.1.4 North America Immunomodulators Market Forecasts and Analysis - By Application
9.1.5 North America Immunomodulators Market Forecasts and Analysis - By Countries
9.1.5.1 United States Immunomodulators Market
9.1.5.1.1 United States Immunomodulators Market by Product
9.1.5.1.2 United States Immunomodulators Market by Application
9.1.5.2 Canada Immunomodulators Market
9.1.5.2.1 Canada Immunomodulators Market by Product
9.1.5.2.2 Canada Immunomodulators Market by Application
9.1.5.3 Mexico Immunomodulators Market
9.1.5.3.1 Mexico Immunomodulators Market by Product
9.1.5.3.2 Mexico Immunomodulators Market by Application
9.2. EUROPE
9.2.1 Europe Immunomodulators Market Overview
9.2.2 Europe Immunomodulators Market Forecasts and Analysis
9.2.3 Europe Immunomodulators Market Forecasts and Analysis - By Product
9.2.4 Europe Immunomodulators Market Forecasts and Analysis - By Application
9.2.5 Europe Immunomodulators Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Immunomodulators Market
9.2.5.1.1 Germany Immunomodulators Market by Product
9.2.5.1.2 Germany Immunomodulators Market by Application
9.2.5.2 France Immunomodulators Market
9.2.5.2.1 France Immunomodulators Market by Product
9.2.5.2.2 France Immunomodulators Market by Application
9.2.5.3 Italy Immunomodulators Market
9.2.5.3.1 Italy Immunomodulators Market by Product
9.2.5.3.2 Italy Immunomodulators Market by Application
9.2.5.4 Spain Immunomodulators Market
9.2.5.4.1 Spain Immunomodulators Market by Product
9.2.5.4.2 Spain Immunomodulators Market by Application
9.2.5.5 United Kingdom Immunomodulators Market
9.2.5.5.1 United Kingdom Immunomodulators Market by Product
9.2.5.5.2 United Kingdom Immunomodulators Market by Application
9.2.5.6 Rest of Europe Immunomodulators Market
9.2.5.6.1 Rest of Europe Immunomodulators Market by Product
9.2.5.6.2 Rest of Europe Immunomodulators Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Immunomodulators Market Overview
9.3.2 Asia-Pacific Immunomodulators Market Forecasts and Analysis
9.3.3 Asia-Pacific Immunomodulators Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Immunomodulators Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Immunomodulators Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Immunomodulators Market
9.3.5.1.1 Australia Immunomodulators Market by Product
9.3.5.1.2 Australia Immunomodulators Market by Application
9.3.5.2 China Immunomodulators Market
9.3.5.2.1 China Immunomodulators Market by Product
9.3.5.2.2 China Immunomodulators Market by Application
9.3.5.3 India Immunomodulators Market
9.3.5.3.1 India Immunomodulators Market by Product
9.3.5.3.2 India Immunomodulators Market by Application
9.3.5.4 Japan Immunomodulators Market
9.3.5.4.1 Japan Immunomodulators Market by Product
9.3.5.4.2 Japan Immunomodulators Market by Application
9.3.5.5 South Korea Immunomodulators Market
9.3.5.5.1 South Korea Immunomodulators Market by Product
9.3.5.5.2 South Korea Immunomodulators Market by Application
9.3.5.6 Rest of Asia-Pacific Immunomodulators Market
9.3.5.6.1 Rest of Asia-Pacific Immunomodulators Market by Product
9.3.5.6.2 Rest of Asia-Pacific Immunomodulators Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Immunomodulators Market Overview
9.4.2 Middle East and Africa Immunomodulators Market Forecasts and Analysis
9.4.3 Middle East and Africa Immunomodulators Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Immunomodulators Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Immunomodulators Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Immunomodulators Market
9.4.5.1.1 South Africa Immunomodulators Market by Product
9.4.5.1.2 South Africa Immunomodulators Market by Application
9.4.5.2 Saudi Arabia Immunomodulators Market
9.4.5.2.1 Saudi Arabia Immunomodulators Market by Product
9.4.5.2.2 Saudi Arabia Immunomodulators Market by Application
9.4.5.3 U.A.E Immunomodulators Market
9.4.5.3.1 U.A.E Immunomodulators Market by Product
9.4.5.3.2 U.A.E Immunomodulators Market by Application
9.4.5.4 Rest of Middle East and Africa Immunomodulators Market
9.4.5.4.1 Rest of Middle East and Africa Immunomodulators Market by Product
9.4.5.4.2 Rest of Middle East and Africa Immunomodulators Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Immunomodulators Market Overview
9.5.2 South and Central America Immunomodulators Market Forecasts and Analysis
9.5.3 South and Central America Immunomodulators Market Forecasts and Analysis - By Product
9.5.4 South and Central America Immunomodulators Market Forecasts and Analysis - By Application
9.5.5 South and Central America Immunomodulators Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Immunomodulators Market
9.5.5.1.1 Brazil Immunomodulators Market by Product
9.5.5.1.2 Brazil Immunomodulators Market by Application
9.5.5.2 Argentina Immunomodulators Market
9.5.5.2.1 Argentina Immunomodulators Market by Product
9.5.5.2.2 Argentina Immunomodulators Market by Application
9.5.5.3 Rest of South and Central America Immunomodulators Market
9.5.5.3.1 Rest of South and Central America Immunomodulators Market by Product
9.5.5.3.2 Rest of South and Central America Immunomodulators Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. IMMUNOMODULATORS MARKET, KEY COMPANY PROFILES
11.1. F. HOFFMANN-LA ROCHE LTD.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. AMGEN, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ABBOTT LABORATORIES
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. JOHNSON AND JOHNSON
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BRISTOL-MYERS SQUIBB COMPANY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND CO., INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ELI LILLY AND COMPANY
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BIOGEN INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. F. Hoffmann-La Roche Ltd.
2. Amgen, Inc.
3. Abbott Laboratories
4. Johnson & Johnson
5. Novartis AG
6. Bristol-Myers Squibb Company
7. Merck & Co., Inc.
8. Eli Lilly and Company
9. Pfizer Inc.
10. Biogen Inc.